Soleus Capital Management’s CVS Health CVS Stock Holding History

Soleus Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,500	Closed	-$4.7M	–	95
2023 Q4	$4.7M	Sell	59,500 -133,054	-69%	-$9.47M	0.52%	45
2023 Q3	$13.4M	Sell	192,554 -162,500	-46%	-$11.5M	1.24%	28
2023 Q2	$24.5M	Buy	355,054 +111,500	+46%	+$7.93M	2.73%	11
2023 Q1	$18.1M	Buy	243,554 +148,800	+157%	+$12.5M	1.87%	13
2022 Q4	$8.83M	Sell	94,754 -191,146	-67%	-$18.4M	1.27%	26
2022 Q3	$27.3M	Buy	285,900 +66,500	+30%	+$6.58M	3.7%	6
2022 Q2	$20.3M	Buy	219,400 +126,900	+137%	+$12.4M	3.17%	7
2022 Q1	$9.36M	Sell	92,500 -45,500	-33%	-$4.78M	1.21%	29
2021 Q4	$14.2M	Buy	+138,000	New	+$12.8M	1.43%	24

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Soleus Capital Management's CVS Position: Q1 2024 in Review

Soleus Capital Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 59,500 shares — an estimated $4.7M sold.

Soleus Capital Management first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $27.3M in Q3 2022. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Soleus Capital Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
Soleus Capital Management sold 59,500 CVS Health shares in Q1 2024, an estimated $4.7M.
Soleus Capital Management first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
Soleus Capital Management's CVS Health position peaked at $27.3M in Q3 2022.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Soleus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.